Erythroderma Latest Advances

Find the Latest Research About Erythroderma

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3410 publications

COVID-19-associated cutaneous vasculitis with exfoliative erythroderma and extensive scarring: Long-term clinical and laser management.

COVID-19-associated cutaneous vasculitis with exfoliative erythroderma and extensive scarring: Long-term clinical and laser management.

Journal: JAAD case reports
Published: June 24, 2026

Photodistributed exfoliative dermatitis associated with semaglutide: Expanding the spectrum of glucagon-like peptide-1 receptor agonist-associated cutaneous reactions.

Photodistributed exfoliative dermatitis associated with semaglutide: Expanding the spectrum of glucagon-like peptide-1 receptor agonist-associated cutaneous reactions.

Journal: JAAD case reports
Published: May 25, 2026

Graft-Versus-Host Disease-like Erythroderma in the Setting of Thymoma: A Rare Paraneoplastic Disorder.

Graft-Versus-Host Disease-like Erythroderma in the Setting of Thymoma: A Rare Paraneoplastic Disorder.

Journal: The American Journal of dermatopathology
Published: May 21, 2026

Clinical Spectrum of Hypersensitivity and Granulomatous Reactions to VenaSeal™ Cyanoacrylate Closure.

Clinical Spectrum of Hypersensitivity and Granulomatous Reactions to VenaSeal™ Cyanoacrylate Closure.

Journal: Dermatitis : contact, atopic, occupational, drug
Published: May 04, 2026

Flow Cytometry for Diagnosing Sézary Syndrome When Skin Biopsies Are Inconclusive: A Case Report.

Flow Cytometry for Diagnosing Sézary Syndrome When Skin Biopsies Are Inconclusive: A Case Report.

Journal: Cureus
Published: April 16, 2026

Exfoliative Erythroderma Revealing Primary Central Nervous System Diffuse Large B-Cell Lymphoma.

Exfoliative Erythroderma Revealing Primary Central Nervous System Diffuse Large B-Cell Lymphoma.

Journal: Cureus
Published: April 11, 2026

Cutaneous adverse events with antibody-drug conjugates: a FAERS-based pharmacovigilance study.

Cutaneous adverse events with antibody-drug conjugates: a FAERS-based pharmacovigilance study.

Journal: Frontiers in medicine
Published: April 03, 2026

Severe graft-versus-host disease-like erythroderma in the setting of thymoma-associated multiorgan autoimmunity.

Severe graft-versus-host disease-like erythroderma in the setting of thymoma-associated multiorgan autoimmunity.

Journal: Medicina clinica
Published: March 28, 2026

Paraneoplastic Papuloerythroderma of Ofuji Masquerading as Worsening Psoriasis.

Paraneoplastic Papuloerythroderma of Ofuji Masquerading as Worsening Psoriasis.

Journal: Psoriasis (Auckland, N.Z.)
Published: March 24, 2026

Comprehensive pharmacovigilance analysis of lebrikizumab: a real-world safety assessment based on the FDA Adverse Event Reporting System (FAERS) database.

Comprehensive pharmacovigilance analysis of lebrikizumab: a real-world safety assessment based on the FDA Adverse Event Reporting System (FAERS) database.

Journal: Immunopharmacology and immunotoxicology
Published: March 23, 2026

Clinical Characteristics, Etiologies, Management, and Outcomes of Adult Exfoliative Dermatitis at Chao Phraya Abhaibhubejhr Hospital, Thailand: A Prospective Cohort Study.

Clinical Characteristics, Etiologies, Management, and Outcomes of Adult Exfoliative Dermatitis at Chao Phraya Abhaibhubejhr Hospital, Thailand: A Prospective Cohort Study.

Journal: Cureus
Published: March 14, 2026

A Case of Toxic Epidermal Necrolysis-Like Dermatosis Associated With Contact Exposure to a Flurbiprofen Plaster.

A Case of Toxic Epidermal Necrolysis-Like Dermatosis Associated With Contact Exposure to a Flurbiprofen Plaster.

Journal: Cureus
Published: February 21, 2026
Showing 1-12 of 3,410

Last Updated: 06/30/2026